Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) Short Interest Update

Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) saw a significant decline in short interest in the month of February. As of February 27th, there was short interest totaling 443,115 shares, a decline of 30.5% from the February 12th total of 637,842 shares. Based on an average trading volume of 157,063 shares, the short-interest ratio is presently 2.8 days. Based on an average trading volume of 157,063 shares, the short-interest ratio is presently 2.8 days.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the business. Kestra Advisory Services LLC bought a new position in shares of Inspira Technologies OXY B.H.N. in the fourth quarter valued at approximately $71,000. Citadel Advisors LLC acquired a new position in shares of Inspira Technologies OXY B.H.N. in the third quarter worth about $105,000. Finally, Yorkville Advisors Global LP purchased a new position in shares of Inspira Technologies OXY B.H.N. in the fourth quarter worth approximately $1,605,000. Institutional investors own 12.72% of the company’s stock.

Inspira Technologies OXY B.H.N. Price Performance

NASDAQ IINN traded up $0.03 on Monday, hitting $0.59. The stock had a trading volume of 33,285 shares, compared to its average volume of 682,707. The company’s 50-day moving average is $0.71 and its two-hundred day moving average is $0.96. Inspira Technologies OXY B.H.N. has a one year low of $0.40 and a one year high of $1.65. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.15 and a quick ratio of 0.90.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reissued a “sell (d-)” rating on shares of Inspira Technologies OXY B.H.N. in a report on Monday, December 29th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $2.00.

About Inspira Technologies OXY B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.